venlafaxine hydrochloride

Generic: venlafaxine

Labeler: rising pharma holdings, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name venlafaxine hydrochloride
Generic Name venlafaxine
Labeler rising pharma holdings, inc.
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

venlafaxine hydrochloride 225 mg/1

Manufacturer
Rising Pharma Holdings, Inc.

Identifiers & Regulatory

Product NDC 64980-581
Product ID 64980-581_7f187899-ddc6-4e15-b2af-e54f59d5baf4
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA216044
Listing Expiration 2026-12-31
Marketing Start 2022-11-28

Pharmacologic Class

Classes
norepinephrine uptake inhibitors [moa] serotonin uptake inhibitors [moa] serotonin and norepinephrine reuptake inhibitor [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 64980581
Hyphenated Format 64980-581

Supplemental Identifiers

RxCUI
808744 808748 808751 808753
UPC
0364980578035 0364980579032 0364980581035 0364980580038
UNII
7D7RX5A8MO

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name venlafaxine hydrochloride (source: ndc)
Generic Name venlafaxine (source: ndc)
Application Number ANDA216044 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 225 mg/1
source: ndc
Packaging
  • 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (64980-581-03)
  • 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (64980-581-09)
source: ndc

Packages (2)

64980-581-03 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (64980-581-03) 64980-581-09 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (64980-581-09)

Ingredients (1)

venlafaxine hydrochloride (225 mg/1)

Linked Drug Pages (1)

Venlafaxine Hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "7f187899-ddc6-4e15-b2af-e54f59d5baf4", "openfda": {"upc": ["0364980578035", "0364980579032", "0364980581035", "0364980580038"], "unii": ["7D7RX5A8MO"], "rxcui": ["808744", "808748", "808751", "808753"], "spl_set_id": ["074f4478-e81b-45a2-ae85-ffd27bed940f"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (64980-581-03)", "package_ndc": "64980-581-03", "marketing_start_date": "20221128"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (64980-581-09)", "package_ndc": "64980-581-09", "marketing_start_date": "20221128"}], "brand_name": "Venlafaxine Hydrochloride", "product_id": "64980-581_7f187899-ddc6-4e15-b2af-e54f59d5baf4", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Norepinephrine Uptake Inhibitors [MoA]", "Serotonin Uptake Inhibitors [MoA]", "Serotonin and Norepinephrine Reuptake Inhibitor [EPC]"], "product_ndc": "64980-581", "generic_name": "Venlafaxine", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Venlafaxine Hydrochloride", "active_ingredients": [{"name": "VENLAFAXINE HYDROCHLORIDE", "strength": "225 mg/1"}], "application_number": "ANDA216044", "marketing_category": "ANDA", "marketing_start_date": "20221128", "listing_expiration_date": "20261231"}